Related Experiment Videos

[Study of the susceptibility of Staphylococcus sp. and Enterococcus sp. to teicoplanin and vancomycin]

I Mimica1, C M Mendes, L Mimica

  • 1Faculdade de Ciências Médicas da Santa Casa de São Paulo.

Revista Da Associacao Medica Brasileira (1992)
|July 1, 1996
PubMed
Abstract

Insights

Teicoplanin and vancomycin show high effectiveness against Staphylococcus aureus and Enterococcus strains. Some coagulase-negative Staphylococcus strains exhibited intermediate susceptibility to teicoplanin.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Context:

  • Antibiotic resistance is a growing global health concern.
  • Enterococcus and Staphylococcus species are common causes of hospital-acquired infections.
  • Evaluating antimicrobial susceptibility is crucial for effective treatment strategies.

Purpose:

  • To assess the in vitro susceptibility of Enterococcus and Staphylococcus isolates to teicoplanin and vancomycin.
  • To compare the efficacy of teicoplanin and vancomycin against these bacterial pathogens.
  • To identify potential resistance patterns in Brazilian hospital settings.

Summary:

  • 150 Enterococcus and 450 Staphylococcus strains (including S. aureus and coagulase-negative staphylococci) were tested.
  • Minimum Inhibitory Concentrations (MICs) were determined using E Test strips and disk diffusion assays.
  • All S. aureus strains were susceptible; some coagulase-negative staphylococci showed intermediate teicoplanin susceptibility, and some Enterococcus strains showed intermediate vancomycin susceptibility.

Impact:

  • Teicoplanin and vancomycin are confirmed as effective therapeutic options for staphylococcal and enterococcal infections.
  • The study provides valuable data on antimicrobial resistance patterns in Brazil.
  • Findings support the continued use of these antibiotics while highlighting the need for ongoing surveillance.

Related Concept Videos